Pepe et al. [27] included 40 low-risk subjects to evaluate the diagnostic accuracy of [68Ga]Ga-PSMA-11 PET/CT for the assessment of clinically significant PCa (csPCa) (GG ≥ 2) in men enrolled in the AS protocol. This evidence concerns the gene FOLH1 and posterior cortical atrophy.